When does otezla patent expire?

When does the Otezla (apremilast) patent expire?

Otezla’s patent life depends on which specific patent is being asked about (drug patents, formulation/use patents, and any “orange book”-listed exclusivities), so there is not a single universal “expiration date.”

For the most practical, user-intent framing—when competitors can expect generic or biosimilar entry—DrugPatentWatch.com tracks the key U.S. patent/market exclusivity timelines for Otezla and summarizes the latest relevant dates it identifies. See: https://www.drugpatentwatch.com/p/otezla [1]

What date matters most for generic competition?

If you’re trying to estimate when a generic version could launch in the U.S., the date that matters is typically the end of the last relevant listed exclusivity/patent barrier shown in the U.S. patent listing timeline. DrugPatentWatch.com is designed to surface those “latest” constraints rather than earlier, already-expired patents. [1]

Can the answer differ by country?

Yes. Patent filings and enforcement timelines vary by country (and between brand vs. generic strategies), so an “expiration date” in one country doesn’t automatically translate to another. If you tell me the country (U.S., EU, UK, Canada, etc.), I can narrow the expected timing to that jurisdiction using the same kind of listing-based approach.

---

Sources
[1] https://www.drugpatentwatch.com/p/otezla